CliffBio
small molecule

INDOMETHACIN

INDOMETHACIN

Loss of exclusivity—loss of exclusivity
CompanyCycle Pharmaceuticals →See this company's full patent-cliff portfolio

Drug detail

Brand nameINDOMETHACIN
Active ingredientINDOMETHACIN
Strength50MG
Dosage formCAPSULE
RouteORAL
ModalitySmall molecule
FDA approvalJune 1985
Marketing statusDISCN

More from Cycle Pharmaceuticals

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

INDOMETHACIN patent cliff — loss of exclusivity — | CliffBio